×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
Please choose a citation manager
RIS (ProCite, Reference Manager)
BibTeX
Content to export
Citation
Citation and abstract
Export
Close ×
Home
Journals Online
Just Accepted
Current Issue
Archive
Most Read
Most Download
Most Cited
E-mail Alert
中文
Home
About Journal
Instruction
Journals Online
Just Accepted
Current Issue
Archive
Most Read
Most Download
Most Cited
E-mail Alert
Editorial Board
Publishing Policy
Download
Contacts Us
中文
Author Login
Peer Review
Office Work
Editor-in-Chief
Volume 40 Issue 2
Directed：
National Medical Products Administration
Sponsored:
National Institutes for Food and Drug Control
Editor in Chief:
AN Fudong
Edited & Published:
Editors Agency of
Chinese Pharmaceutical Affairs
ISSN:
1002-7777
CN:
11-2858/R
Highlights
More
Collections
More +
Current Issue
Archive
Most Download
Most Read
Most Cited
Volume 40 Issue 2
20 February 2026
Supervision & Administration
Internal Logic and Implementation Pathways for AI-Driven Upgrading of Traditional Chinese Medicine Value Chain
Yuan Junli, Feng Zhipei, Yang Hupo, Wang Ying
2026, 40(2): 127-134.
https://doi.org/10.16153/j.1002-7777.2025-08-0001
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Development of Drug Regulatory Informatization and Reflections on the Path Towards Intelligent Regulation in China
Yu Miao, Wen Qinghui, Li Meng
2026, 40(2): 135-140.
https://doi.org/10.16153/j.1002-7777.2025-09-0051
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Analysis and Reflections on the Differences in Quality Regulation of Drug Clinical Trials Between Domestic and International Practices
Li Xiaojuan, Tian Lijuan
2026, 40(2): 141-147.
https://doi.org/10.16153/j.1002-7777.2025-07-0005
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Research on the Integration of Research and Review of Medical Devices and Its Implementation Path
Li Mingyang, Pang Bo
2026, 40(2): 148-153.
https://doi.org/10.16153/j.1002-7777.2025-07-0011
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Analysis of the Current Situation of Drug Supervision and Sampling Inspection in Shaanxi Local Municipalities and Suggestions
Xiao Yu, Peng Rui
2026, 40(2): 154-159.
https://doi.org/10.16153/j.1002-7777.2025-06-0010
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Research on Optimization of Healthcare Institution Regulatory Mechanisms Based on Pharmaceutical Administrative Penalty Case Profiles in Sanming
Wu Lianbin
2026, 40(2): 160-166.
https://doi.org/10.16153/j.1002-7777.2025-06-0037
Abstract
(
)
Download PDF
(
)
Quality Management
Risk Analysis and Countermeasure Discussion on the Processing Technology Validation in the Industrial Production of Chinese Herbal Decoction Pieces
Tang Yong, You Zhengqin, Song Chunping, Ren Pengyu, Li Wei
2026, 40(2): 167-174.
https://doi.org/10.16153/j.1002-7777.2025-07-0065
Abstract
(
)
Download PDF
(
)
Quality Management
Research on the Application of Radio Frequency Identification Technology in the Management of National Drug Reference Standards
Wang Yajun, Wang Yu, Liu Zeqian, Yin Huidong, Liu Mingli
2026, 40(2): 175-181.
https://doi.org/10.16153/j.1002-7777.2025-09-0009
Abstract
(
)
Download PDF
(
)
Regulatory Technology
Evaluation and Optimization of the Performance of Acetamiprid Colloidal Gold Immunochromatographic Test Strips in Lycii Fructus
Zhou Tingting, Liu Yuanxi, Xie Xuan, Wang Dandan, Jin Hongyu, Wei Feng, Wang Miao, Wang Ying
2026, 40(2): 182-193.
https://doi.org/10.16153/j.1002-7777.2025-07-0077
Abstract
(
)
Download PDF
(
)
More +
More +
More +
More +
More +
Links
More
